Immunogenicity and Safety of GSK Biologicals' FluLaval® TF

Summary

The present study is intended to assess a novel formulation of FluLaval. The idea is to obtain preliminary data on the safety and immune response to the FluLaval TF influenza vaccine in adults. These data will serve as a basis for further studies involving different populations. This protocol posting deals with objectives \& outcome measures of the primary phase/study.

Timeline

Start

2008-08-05

Primary completion

2008-08-29

Completion

2009-02-17

Drugs

Indications